Author name: comtex

Guardforce AI Implements Smart Solutions and AI Applications in Thailand

Guardforce AI Implements Smart Solutions and AI Applications in Thailand Launched Strategy Toward AI-Driven Growth GlobeNewswire July 28, 2025 NEW YORK, NY, July 28, 2025 (GLOBE NEWSWIRE) — Guardforce AI Co., Limited (Nasdaq: GFAI, GFAIW) (“Guardforce AI” or the “Company”), a global integrated security solutions provider specializing in secured logistics, AI, and Robot-as-a-Service (RaaS), today […]

UroGen Announces Publication of Phase 3b Study Results Demonstrating the Feasibility of Home Instillation of ZUSDURI(TM) for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer in Reviews in Urology

UroGen Announces Publication of Phase 3b Study Results Demonstrating the Feasibility of Home Instillation of ZUSDURI(TM) for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer in Reviews in Urology GlobeNewswire July 28, 2025 PRINCETON, N.J., July 28, 2025 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative treatments

Vertex Report: U.S. Sees Continued Acceleration in Sales Tax Rates and Rules Changes

Vertex Report: U.S. Sees Continued Acceleration in Sales Tax Rates and Rules Changes Vertex's 2025 Mid-Year Report reveals more than 400 implemented changes to U.S. sales tax rates and rules nationwide, highlighting growing compliance complexity for businesses GlobeNewswire July 28, 2025 KING OF PRUSSIA, Pa., July 28, 2025 (GLOBE NEWSWIRE) — Vertex Inc. (NASDAQ:VERX) (“Vertex”

Deliverect Partners with FreedomPay to Transform Payment Operations for Restaurant Chains

Deliverect Partners with FreedomPay to Transform Payment Operations for Restaurant Chains Strategic partnership provides multi-location QSRs and enterprise restaurants with flexible payment technology to enhance omnichannel capabilities and simplify operations GlobeNewswire July 28, 2025 Philadelphia, PA, July 28, 2025 (GLOBE NEWSWIRE) — Deliverect, a leading global food tech SaaS company, announces a strategic worldwide partnership

The U.S. Has the Minerals. Now It Has the Mechanism.

The U.S. Has the Minerals. Now It Has the Mechanism. In a powerful presentation, former CIA advisor Jim Rickards reveals how a forgotten federal provision could quietly unlock America's control over critical technology resources GlobeNewswire July 28, 2025 Washington, D.C., July 28, 2025 (GLOBE NEWSWIRE) — What If America's Tech Dominance Doesn't Come from Silicon

Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results

Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results GlobeNewswire July 28, 2025 SOMERSET, N.J., July 28, 2025 (GLOBE NEWSWIRE) — Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Monday, August 11, 2025, to review

Changes in Nokia Corporation’s own shares

Changes in Nokia Corporation's own shares GlobeNewswire July 28, 2025 Nokia CorporationStock Exchange Release28 July 2025 at 15:00 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 325 584 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia's equity-based incentive plans in accordance with

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status of Common Share Repurchase Program GlobeNewswire July 28, 2025 STMicroelectronics Announces Status ofCommon Share Repurchase Program Disclosure of Transactions in Own Shares – Period from July 21, 2025 to July 25, 2025 AMSTERDAM – July 28, 2025 — STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global semiconductor leader serving customers across the

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01) GlobeNewswire July 28, 2025 Lu177-B7H3 monoclonal antibody is first in class targeted radiopharmaceutical in development against the 4lg subtype of B7-H3 On track to initiate first-in-human study of RV-01 in solid tumors in 4Q25

ProQR Announces Upcoming Presentation at RNA Editing Summit

ProQR Announces Upcoming Presentation at RNA Editing Summit GlobeNewswire July 28, 2025 LEIDEN, Netherlands & CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) — ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer(TM) RNA editing technology platform, today announced that it will participate in

Scroll to Top